Despite near-term headwinds posed by supply chain disruptions, DBS believes the medical equipment segment represents a strong area of growth for healthcare. Ageing populations, the prevalence of chronic diseases and growing demand for innovative devices and services underpin the sector’s expansion potential, adds Hou.
DBS remains “neutral” weight on equities for 4QFY2022 ended December, advocating investors to stay with quality companies with deep moats and pricing power such as those within the healthcare and luxury sectors, says CIO Hou Wey Fook.
During the media briefing for the 4QFY2022 CIO Insights report, Hou reiterates healthcare and luxury as two long-term secular themes that are beneficiaries of demographic changes and new lifestyle choices.
